Belarus vs Serbia: Cause of death, by non-communicable diseases, ages 15-59, male
Belarus
63.7%
in 2021
Serbia
63.8%
in 2021
Belarus rank
49th
Serbia rank
48th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Belarus
- Serbia
How they compare
Serbia currently reports 63.8% against 63.7% in Belarus, a difference of 0.1%.
Across all 6 years both countries report, Serbia has been ahead every year.
Belarus ranks 49th and Serbia ranks 48th of 185 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.4% | 79.5% | 17.1% | Serbia |
| 2010s | 72.8% | 83.7% | 11.0% | Serbia |
| 2020s | 65.0% | 67.8% | 2.8% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Belarus or Serbia?
- Serbia, at 63.8% against 63.7% in Belarus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Belarus and Serbia?
- 0.1%, with Serbia ahead.
- How many years of comparable data are there for Belarus and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Belarus and Serbia rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Belarus ranks 49th and Serbia ranks 48th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.